Other languages Aurobindo Pharma

Equities

AUROPHARMA

INE406A01037

Delayed NSE India S.E. Other stock markets 06:28:08 2024-06-13 am EDT			5-day change	1st Jan Change
1,255 ^INR	+0.46%		+0.27%	+15.74%

Jun. 05	Hindalco-owned Novelis delays US IPO; shares slide	RE
May. 27	Aurobindo Pharma Clocks Gains in Fiscal Q4 Consolidated Net Profit	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Hindalco-owned Novelis delays US IPO; shares slide	Jun. 04
Aurobindo Pharma Clocks Gains in Fiscal Q4 Consolidated Net Profit	May. 27
Aurobindo Pharma Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024	May. 25
India's Hindalco mulls seeking $1.2 bln in Novelis IPO, Bloomberg News reports	May. 08
Aurobindo Pharma Completes Sale of US Arm's Business Assets	May. 02
Aurobindo Pharma Limited Announces Appointment of T. Vijaya Kumar as President R&D (Specialty Drug Delivery)	Apr. 06
Aurobindo Pharma Arms Commission Four New Plants in Andhra Pradesh, India	Apr. 02
Aurobindo Pharma Limited Announces Retirement of K. Ragunathan as Chairman of Board of Directors, Effective March 31, 2024	Mar. 27
Indian shares set to track Asian peers higher, eye on Fed meet	Mar. 19
Aurobindo Pharma Gets US FDA Final Nod for Mometasone Furoate Monohydrate Nasal Spray	Mar. 19
Aurobindo Pharma Limited Receives Final Approval from the US Food & Drug Administration	Mar. 19
Aurobindo Pharma Arm Restarts Distribution of Aseptic Products from Unit III	Mar. 12
Aurobindo Pharma Limited Appoints N. Ravikiran as Chief Business Officer	Mar. 05
Aurobindo Pharma Limited Receives USFDA Approval for Fingolimod Capsules, 0.5 Mg	Mar. 01
Indian shares set to rise on strong domestic growth, in-line US inflation data	Feb. 29
US FDA Completes Inspection of Aurobindo Pharma's Injectibles Unit	Feb. 29
US FDA Clears Aurobindo Pharma Arm's Manufacturing Unit in Telangana, India	Feb. 16
INDIA STOCKS-Auto stocks drive Indian shares higher	Feb. 16
Aurobindo Pharma Limited Receives USFDA Approval for Deflazacort Tablets, 6 mg, 18 mg, 30 mg, and 36 mg	Feb. 12
Aurobindo Pharma Clocks Gains in Fiscal Q3 Consolidated Net Profit	Feb. 12

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Aurobindo Pharma

Equities

AUROPHARMA

INE406A01037

Other languages

Filters